Skip to main content

Advertisement

SpringerLink
Log in

Oxidative stress and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives

  • Published:
Reviews in Endocrine and Metabolic Disorders Aims and scope Submit manuscript

Abstract

Retinopathy is one of the most severe ocular complications of diabetes and is a leading cause of acquired blindness in young adults. The cellular components of the retina are highly coordinated but very susceptible to the hyperglycemic environment. The microvasculature of the retina responds to hyperglycemic milieu through a number of biochemical changes, including increased oxidative stress and polyol pathway, PKC activation and advanced glycation end product formation. Oxidative stress is considered as one of the crucial contributors in the pathogenesis of diabetic retinopathy, but oxidative stress appears to be highly interrelated with other biochemical imbalances that lead to structural and functional changes and accelerated loss of capillary cells in the retinal microvasculature and, ultimately, pathological evidence of the disease. One such potential connection that links oxidative stress to metabolic alterations is gyceraldehyde-3-phosphate dehydrogenase whose activity is impaired in diabetes, and that results in activation of other major pathways implicated in the pathogenesis of diabetic retinopathy. Alterations associated with oxidative stress offer many potential therapeutic targets making this an area of great interest to the development of safe and effective treatments for diabetic retinopathy. Animal models of diabetic retinopathy have shown beneficial effects of antioxidants on the development of retinopathy, but clinical trials (though very limited in numbers) have provided somewhat ambiguous results. Although antioxidants are being used for other chronic diseases, controlled clinical trials are warranted to investigate potential beneficial effects of antioxidants in the development of retinopathy in diabetic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53. doi:10.2337/diacare.27.5.1047.

    Article  PubMed  Google Scholar 

  2. American Diabetes Association. Economic costs of diabetes in the U.S. In 2007. Diabetes Care 2008;31:596–615. doi:10.2337/dc08-9017.

    Article  Google Scholar 

  3. National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics fact sheet: general information and national estimates on diabetes in the United States, 2005. Bethesda, MD: U.S. Department of Health and Human Services, National Institute of Health; 2005.

    Google Scholar 

  4. Fisher EB, Thorpe CT, Devellis BM, Devellis RF. Healthy coping, negative emotions, and diabetes management: a systematic review and appraisal. Diabetes Educ. 2007;33:1080–103. doi:10.1177/0145721707309808.

    Article  PubMed  Google Scholar 

  5. Milicevic Z, Raz I, Beattie SD, et al. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia. Diabetes Care. 2008;31:S155–60. doi:10.2337/dc08-s240.

    Article  PubMed  CAS  Google Scholar 

  6. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002;287:2563–9. doi:10.1001/jama.287.19.2563.

    Article  Google Scholar 

  7. Engerman RL, Kern TS. Hyperglycemia as a cause of diabetic retinopathy. Metabolism. 1986;35:20–3. doi:10.1016/0026-0495(86)90182-4.

    Article  PubMed  CAS  Google Scholar 

  8. Sharma S, Oliver-Fernandez A, Liu W, Buchholz P, Walt J. The impact of diabetic retinopathy on health-related quality of life. Curr Opin Ophthalmol. 2005;16:155–9. doi:10.1097/01.icu.0000161227.21797.3d.

    Article  PubMed  Google Scholar 

  9. Lorenzi M, Gerhardinger C. Early cellular and microvascular changes induced by diabetes in the retina. Diabetologia. 2001;44:791–804. doi:10.1007/s001250100544.

    Article  PubMed  CAS  Google Scholar 

  10. Harhaj NS, Antonetti DA. Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol. 2004;36:1206–37. doi:10.1016/j.biocel.2003.08.007.

    Article  PubMed  CAS  Google Scholar 

  11. Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350:48–58. doi:10.1056/NEJMra021678.

    Article  PubMed  CAS  Google Scholar 

  12. D’Amico DJ. Diseases of the retina. N Engl J Med. 1994;331:95–106. doi:10.1056/NEJM199407143310207.

    Article  PubMed  CAS  Google Scholar 

  13. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest. 1998;102:783–91. doi:10.1172/JCI2425.

    Article  PubMed  CAS  Google Scholar 

  14. Kowluru RA. Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are inter-related. Acta Diabetol. 2001;38:179–85. doi:10.1007/s592-001-8076-6.

    Article  PubMed  CAS  Google Scholar 

  15. Kowluru RA, Koppolu P. Diabetes-induced activation of caspase-3 in retina: effect of antioxidant therapy. Free Radic Res. 2002;36:993–9. doi:10.1080/1071576021000006572.

    Article  PubMed  CAS  Google Scholar 

  16. Kowluru RA, Koppolu P, Chakrabarti S, Chen S. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic Res. 2003;37:1169–80. doi:10.1080/10715760310001604189.

    Article  PubMed  CAS  Google Scholar 

  17. Kowluru RA, Abbas SN. Diabetes-induced mitochondrial dysfunction in the retina. Invest Ophthalmol Vis Sci. 2003;44:5327–34. doi:10.1167/iovs.03-0353.

    Article  PubMed  Google Scholar 

  18. Kowluru RA, Kowluru A, Chakrabarti S, Khan Z. Potential contributory role of H-Ras, a small G-protein, in the development of retinopathy in diabetic rats. Diabetes. 2004;53:775–83. doi:10.2337/diabetes.53.3.775.

    Article  PubMed  CAS  Google Scholar 

  19. Kowluru RA, Odenbach S. Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. Br J Ophthalmol. 2004;88:1343–7. doi:10.1136/bjo.2003.038133.

    Article  PubMed  CAS  Google Scholar 

  20. Du Y, Sarthy VP, Kern TS. Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats. Am J Physiol Regul Integr Comp Physiol. 2004;287:R734–41. doi:10.1152/ajpregu.00080.2003.

    Google Scholar 

  21. Kowluru RA, Atasi L, Ho YS. Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2006;47:1594–9. doi:10.1167/iovs.05-1276.

    Article  PubMed  Google Scholar 

  22. Vincent JA, Mohr S. Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes. 2007;56:224–30. doi:10.2337/db06-0427.

    Article  PubMed  CAS  Google Scholar 

  23. Kern TS, Barber AJ. Retinal ganglion cells in diabetes. Am J Physiol. 2008, Epub ahead of print, PMID:18565995.

  24. Mohr S, Xi X, Tang J, Kern TS. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes. 2002;51:1172–9. doi:10.2337/diabetes.51.4.1172.

    Article  PubMed  CAS  Google Scholar 

  25. Kusner LL, Sarthy VP, Mohr S. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Müller cells. Invest Ophthalmol Vis Sci. 2004;45:1553–61.

    PubMed  Google Scholar 

  26. Mizutani M, Kern TS, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest. 1996;97:2883–90. doi:10.1172/JCI118746.

    Article  PubMed  CAS  Google Scholar 

  27. Kern TS, Tang J, Mizutani M, Kowluru R, Nagraj R, Lorenzi M. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci. 2000;41:3972–8.

    PubMed  CAS  Google Scholar 

  28. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–86. doi:10.1056/NEJM199309303291401.

    Article  Google Scholar 

  29. UKPDS. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837–53. doi:10.1016/S0140-6736(98)07019-6.

  30. Sheth BP. Does pregnancy accelerate the rate of progression of diabetic retinopathy. Curr Diab Rep. 2002;2:327–30. doi:10.1007/s11892-002-0022-5.

    Article  PubMed  Google Scholar 

  31. Dorchy H. Screening for subclinical complications in young type 1 diabetic patients: experience acquired in Brussels. Pediatr Endocrinol Rev. 2004;1:380–403.

    PubMed  Google Scholar 

  32. Wong TY, Mitchell P. The eye in hypertension. Lancet. 2007;369:425–35. doi:10.1016/S0140-6736(07)60198-6.

    Article  PubMed  Google Scholar 

  33. Stitt AW. The role of advanced glycation in the pathogenesis of diabetic retinopathy. Exp Mol Pathol. 2003;75:95–108. doi:10.1016/S0014-4800(03)00035-2.

    Article  PubMed  CAS  Google Scholar 

  34. Baynes JW, Thrope SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999;48:1–9. doi:10.2337/diabetes.48.1.1.

    Article  PubMed  CAS  Google Scholar 

  35. Kowluru RA, Tang J, Kern TS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 2001;50:1938–42. doi:10.2337/diabetes.50.8.1938.

    Article  PubMed  CAS  Google Scholar 

  36. Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL. Characterization of the mechanism for the chronic activation of DAG–PKC pathway in diabetes and hypergalactosemia. Diabetes. 1994;43:1122–9. doi:10.2337/diabetes.43.9.1122.

    Article  PubMed  CAS  Google Scholar 

  37. Aiello LP, Wong JS. Role of vascular endothelial growth factor in diabetic vascular complications. Kidnet Int. 2000;77:S113–9. doi:10.1046/j.1523-1755.2000.07718.x.

    Article  CAS  Google Scholar 

  38. Kowluru RA, Kern TS, Engerman RL. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. Free Radic Biol Med. 1997;22:587–92. doi:10.1016/S0891-5849(96)00347-4.

    Article  PubMed  CAS  Google Scholar 

  39. Kowluru RA, Jirousek MR, Stramm LE, Farid NA, Engerman RL, Kern TS. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. V. Relationship between protein kinase C and ATPases. Diabetes. 1998;47:464–9. doi:10.2337/diabetes.47.3.464.

    Article  PubMed  CAS  Google Scholar 

  40. Lorenzi M. The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient. Exp Diabetes Res. 2007;2007:61038.

    PubMed  Google Scholar 

  41. Naruse K, Nakamura J, Hamada Y, et al. Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytes. Exp Eye Res. 2000;71:309–15. doi:10.1006/exer.2000.0882.

    Article  PubMed  CAS  Google Scholar 

  42. Miwa K, Nakamura J, Hamada Y, et al. The role of polyol pathway in glucose-induced apoptosis of cultured retinal pericytes. Diabetes Res Clin Pract. 2003;60:1–9. doi:10.1016/S0168-8227(02)00248-6.

    Article  PubMed  CAS  Google Scholar 

  43. Oates PJ, Mylari BL. Aldose reductase inhibitors: therapeutic implications for diabetic complications. Expert Opin Investig Drugs. 1999;8:2095–119. doi:10.1517/13543784.8.12.2095.

    Article  PubMed  CAS  Google Scholar 

  44. Kador PF, Akagi Y, Takahashi Y, Ikebe H, Wyman M, Kinoshita JH. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. Arch Ophthalmol. 1990;108:1301–9.

    PubMed  CAS  Google Scholar 

  45. Sorbinil Retinopathy Trial Research Group. A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Arch Ophthalmol. 1990;108:1234–44.

    Google Scholar 

  46. Engerman RL, Kern TS. Dissociation of retinopathy and nephropathy in animal models of diabetes: diabetes vs galactosemia. In: Ruderman N, Williamson J, Brownlee M, editors. Hyperglycemia, diabetes and vascular disease. New York: Oxford University Press; 1992. p. 151–61.

    Google Scholar 

  47. Park JY, Takahara N, Gabriele A, et al. Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes. 2000;49:1239–48. doi:10.2337/diabetes.49.7.1239.

    Article  PubMed  CAS  Google Scholar 

  48. Yokota T, Ma RC, Park JY, et al. Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes. Diabetes. 2003;52:838–45. doi:10.2337/diabetes.52.3.838.

    Article  PubMed  CAS  Google Scholar 

  49. Takagi C, Bursell SE, Lin YW, et al. Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Invest Ophthalmol Vis Sci. 1996;37:2504–18.

    PubMed  CAS  Google Scholar 

  50. Aiello LP, Brusell SE, Clermont A, et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta isoform-selective inhibitor. Diabetes. 1997;46:1473–80. doi:10.2337/diabetes.46.9.1473.

    Article  PubMed  CAS  Google Scholar 

  51. Amadio M, Scapagnini G, Lupo G, Drago F, Govoni S, Pascale A. PKCbetaII/HuR/VEGF: a new molecular cascade in retinal pericytes for the regulation of VEGF gene expression. Pharmacol Res. 2008;57:60–6. doi:10.1016/j.phrs.2007.11.006.

    Article  PubMed  CAS  Google Scholar 

  52. Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Vlassara H. Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol. 1997;150:523–31.

    PubMed  CAS  Google Scholar 

  53. Gardiner TA, Anderson HR, Stitt AW. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes. J Pathol. 2003;201:328–33. doi:10.1002/path.1429.

    Article  PubMed  CAS  Google Scholar 

  54. Stitt AW, Hughes SJ, Canning P, et al. Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor. Diabetologia. 2004;47:1735–46. doi:10.1007/s00125-004-1523-3.

    Article  PubMed  CAS  Google Scholar 

  55. Schmidt AM, Hori O, Cao R, et al. A novel cellular receptor for advanced glycation end products. Diabetes. 1996;45(Suppl. 3):S77–80. doi:10.2337/diabetes.45.3.284.

    PubMed  CAS  Google Scholar 

  56. Du X, Matsumura T, Edelstein D, et al. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest. 2003;112:1049–57.

    PubMed  CAS  Google Scholar 

  57. Nakamura M, Barber AJ, Antonetti DA, et al. Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons. J Biol Chem. 2001;47:43748–55. doi:10.1074/jbc.M108594200.

    Article  Google Scholar 

  58. Masson E, Wiernsperger N, Lagarde M, El Bawab S. Involvement of gangliosides in glucosamine-induced proliferation decrease of retinal pericytes. Glycobiology. 2005;15:585–91. doi:10.1093/glycob/cwi039.

    Article  PubMed  CAS  Google Scholar 

  59. Anderson RE, Rapp LM, Wiegand RD. Lipid peroxidation and retinal degeneration. Curr Eye Res. 1984;3:223–7. doi:10.3109/02713688408997203.

    Article  PubMed  CAS  Google Scholar 

  60. Armstrong D, Al-Awadi F. Lipid peroxidation and retinopathy in streptozotocin-induced diabetes. Free Radic Biol Med. 1991;11:433–6. doi:10.1016/0891-5849(91)90161-U.

    Article  PubMed  CAS  Google Scholar 

  61. Kowluru RA. Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxid Redox Signal. 2005;7:1581–7. doi:10.1089/ars.2005.7.1581.

    Article  PubMed  CAS  Google Scholar 

  62. Kanwar M, Chan PS, Kern TS, Kowluru RA. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci. 2007;48:3805–11. doi:10.1167/iovs.06-1280.

    Article  PubMed  Google Scholar 

  63. Robison WG, Jacot JL, Katz ML, Glover JP. Retinal vascular changes induced by the oxidative stress of alpha-tocopherol deficiency contrasted with diabetic microangiopathy. J Ocul Pharmacol Ther. 2000;16:109–20.

    Article  PubMed  CAS  Google Scholar 

  64. Li W, Yanoff M, Jian B, He Z. Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas. Cell Mol Biol. 1999;45:59–66.

    PubMed  CAS  Google Scholar 

  65. Kowluru RA, Kowluru V, Ho YS, Xiong Y. Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. Free Radic Biol Med. 2006;41:1191–6. doi:10.1016/j.freeradbiomed.2006.01.012.

    Article  PubMed  CAS  Google Scholar 

  66. Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47–95.

    PubMed  CAS  Google Scholar 

  67. Saran M, Michel C, Bors W. Reaction of NO with O2−× implications for the action of endothelium-derived relaxing factor (EDRF). Free Radic Res Commun. 1990;10:221–6. doi:10.3109/10715769009149890.

    Article  PubMed  CAS  Google Scholar 

  68. Huie RE, Padmaja S. The reaction of NO with superoxide. Free Radic Res Commun. 1993;18:195–9. doi:10.3109/10715769309145868.

    Article  PubMed  CAS  Google Scholar 

  69. Radi R, Cassina A, Hodara R. Nitric oxide and peroxynitrite interactions with mitochondria. Biol Chem. 2002;383:401–9. doi:10.1515/BC.2002.044.

    Article  PubMed  CAS  Google Scholar 

  70. Anuradha CD, Kanno S, Hirano S. Oxidative damage to mitochondria is a preliminary step to caspase-3 activation in fluoride-induced apoptosis in HL-60 cells. Free Radic Biol Med. 2001;31:367–73. doi:10.1016/S0891-5849(01)00591-3.

    Article  PubMed  CAS  Google Scholar 

  71. Karpinich NO, Tafani M, Rothman RJ, Russo MA, Farber JL. The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c. J Biol Chem. 2002;277:16547–62. doi:10.1074/jbc.M110629200.

    Article  PubMed  CAS  Google Scholar 

  72. Podesta F, Romeo G, Liu WH, et al. Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am J Pathol. 2000;156:1025–32.

    PubMed  CAS  Google Scholar 

  73. Piconi L, Quagliaro L, Ceriello A. Oxidative stress in diabetes. Clin Chem Lab Med. 2003;41:1144–9. doi:10.1515/CCLM.2003.177.

    Article  PubMed  CAS  Google Scholar 

  74. Sakurai T, Tsuchiya S. Superoxide production from nonenzymatically glycated protein. FEBS Lett. 1988;236:406–10. doi:10.1016/0014-5793(88)80066-8.

    Article  PubMed  CAS  Google Scholar 

  75. Inoguchi T, Sonta T, Tsubouchi H, et al. Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol. 2003;14:S227–32. doi:10.1097/01.ASN.0000077407.90309.65.

    Article  PubMed  CAS  Google Scholar 

  76. Haskins K, Bradley B, Powers K, et al. Oxidative stress in Type 1 diabetes. Ann N Y Acad Sci. 2003;1005:43–54. doi:10.1196/annals.1288.006.

    Article  PubMed  CAS  Google Scholar 

  77. Kowluru RA. Diabetic retinopathy, oxidative stress and antioxidants. Curr Top Nutraceutical Res. 2005;3:209–18.

    CAS  Google Scholar 

  78. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapy. Diabetes Care. 2003;26:1589–96. doi:10.2337/diacare.26.5.1589.

    Article  PubMed  CAS  Google Scholar 

  79. Lassègue B, Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol. 2003;285:R277–97.

    PubMed  Google Scholar 

  80. Brownlee M. Negative consequences of glycation. Metabolism. 2000;49:9–13. doi:10.1016/S0026-0495(00)80078-5.

    Article  PubMed  CAS  Google Scholar 

  81. Kowluru RA. Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions. Life Sci. 2005;76:1051–60. doi:10.1016/j.lfs.2004.10.017.

    Article  PubMed  CAS  Google Scholar 

  82. Sennlaub F, Courtois Y, Goureau O. Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy. J Neurosci. 2002;22:3987–93.

    PubMed  CAS  Google Scholar 

  83. Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo. FEBS Lett. 1997;411:157–60. doi:10.1016/S0014-5793(97)00469-9.

    Article  PubMed  CAS  Google Scholar 

  84. Stauble B, Boscoboinik D, Tasinato A, Azzi A. Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and D-a-tocopherol in vascular smooth muscles. Eur J Biochem. 1994;226:393–402. doi:10.1111/j.1432-1033.1994.tb20064.x.

    Article  PubMed  CAS  Google Scholar 

  85. Sen CK, Sashwati R, Packer L. Fas mediated apoptosis of human Jurkat T-cells: intracellular events and potentiation by redox-active alpha-lipoic acid. Cell Death Differ. 1999;6:481–91. doi:10.1038/sj.cdd.4400514.

    Article  PubMed  CAS  Google Scholar 

  86. Gopalkrishna R, Janken S. Protein kinase C signalling and oxidative stress. Free Radic Biol Med. 2000;28:1349–61. doi:10.1016/S0891-5849(00)00221-5.

    Article  Google Scholar 

  87. Ha H, Yoon SJ, Kim KH. High glucose can induce lipid peroxidation in the isolated rat glomeruli. Kidney Int. 1994;46:1620–6. doi:10.1038/ki.1994.461.

    Article  PubMed  CAS  Google Scholar 

  88. Frank RN. Diabetic retinopathy. Prog Retin Eye Res. 1995;14:361–92.

    Article  Google Scholar 

  89. Goh SY, Cooper ME. Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab. 2008;93:1143–52. doi:10.1210/jc.2007-1817.

    Article  PubMed  CAS  Google Scholar 

  90. Khan ZA, Chakrabarti S. Cellular signaling and potential new treatment targets in diabetic retinopathy. Exp Diabetes Res. 2007;2007:31867.

    PubMed  Google Scholar 

  91. Cheng TH, Shih NL, Chen SY, et al. Reactive oxygen species mediate cyclic strain-induced endothelin-1 gene expression via Ras/Raf/extracellular signal-regulated kinase pathway in endothelial cells. J Mol Cell Cardiol. 2001;42:1802–14.

    Google Scholar 

  92. Chen S, Khan ZA, Barbin Y, Chakrabarti S. Pro-oxidant role of heme oxygenase in mediating glucose-induced endothelial cell damage. Free Radic Res. 2004;38:1301–10. doi:10.1080/10715760400017228.

    Article  PubMed  CAS  Google Scholar 

  93. Chen S, Apostolova MD, Cherian MG, Chakrabarti S. Interaction of endothelin-1 with vasoactive factors in mediating glucose-induced increased permeability in endothelial cells. Lab Invest. 2000;80:1311–21.

    Article  PubMed  CAS  Google Scholar 

  94. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson MD. Programmed cell death and the control of cell survival: lessons from the nervous system. Science. 1993;262:695–700. doi:10.1126/science.8235590.

    Article  PubMed  CAS  Google Scholar 

  95. Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. Exp Diabetes Res. 2007;2007:43603.

    PubMed  Google Scholar 

  96. Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M. Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes. 2002;51:2241–8. doi:10.2337/diabetes.51.7.2241.

    Article  PubMed  CAS  Google Scholar 

  97. Kowluru RA, Odenbach S. Effect of long-term administration of alpha lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes. 2004;53:3233–8. doi:10.2337/diabetes.53.12.3233.

    Article  PubMed  CAS  Google Scholar 

  98. Kowluru RA, Kanwar M, Chan PS, Zhang JP. Inhibition of retinopathy and retinal metabolic abnormalities in diabetic rats with AREDS-based micronutrients. Arch Ophthalmol. 2008, (in press).

  99. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54:1615–25. doi:10.2337/diabetes.54.6.1615.

    Article  PubMed  CAS  Google Scholar 

  100. Ola MS, Berkich DA, Xu Y, et al. Analysis of glucose metabolism in diabetic rat retinas. Am J Physiol Endocrinol Metab. 2006;290:E1057–67. doi:10.1152/ajpendo.00323.2005.

    Article  PubMed  CAS  Google Scholar 

  101. Deveze-Alvarez M, Garcia-Soto J, Martinez-Cadena G. Glyceraldehyde-3-phosphate dehydrogenase is negatively regulated by ADP-ribosylation in the fungus Phycomyces blakesleeanus. Microbiology. 2001;147:2579–84.

    PubMed  CAS  Google Scholar 

  102. Zheng L, Szabo C, Kern TS. Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes. 2004;53:2960–7. doi:10.2337/diabetes.53.11.2960.

    Article  PubMed  CAS  Google Scholar 

  103. Sugawara R, Hikichi T, Kitaya N, et al. Peroxynitrite decomposition catalyst, FP15, and poly(ADP-ribose) polymerase inhibitor, PJ34, inhibit leukocyte entrapment in the retinal microcirculation of diabetic rats. Curr Eye Res. 2004;29:11–6.

    Article  PubMed  CAS  Google Scholar 

  104. Obrosova IG, Minchenko AG, Frank RN, et al. Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression. Int J Mol Med. 2004;14:55–64.

    PubMed  CAS  Google Scholar 

  105. Xu B, Chiu J, Feng B, Chen S, Chakrabarti S. PARP activation and the alteration of vasoactive factors and extracellular matrix protein in retina and kidney in diabetes. Diabetes Metab Res Rev. 2008;24:402–12.

    Article  CAS  Google Scholar 

  106. Batthyany C, Schopfer FJ, Baker PR, et al. Reversible post-translational modification of proteins by nitrated fatty acids in vivo. J Biol Chem. 2006;281:450–63. doi:10.1074/jbc.M602814200.

    Article  CAS  Google Scholar 

  107. Padgett CM, Whorton AR. S-nitrosoglutathione reversibly inhibits GAPDH by S-nitrosylation. Am J Physiol. 1995;269:C739–49.

    PubMed  CAS  Google Scholar 

  108. Du Y, Smith MA, Miller CM, Kern TS. Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem. 2002;80:771–9. doi:10.1046/j.0022-3042.2001.00737.x.

    Article  PubMed  CAS  Google Scholar 

  109. Kowluru RA, Chakrabarti S, Chen S. Re-Institution of good metabolic control in diabetic rats on the activation of caspase-3 and nuclear transcriptional factor (NF-kB) in the retina. Acta Diabetol. 2004;44:194–9. doi:10.1007/s00592-004-0165-8.

    Article  CAS  Google Scholar 

  110. Kanski J, Behring A, Pelling J, Schöneich C. Proteomic identification of 3-nitrotyrosine-containing rat cardiac proteins: effects of biological aging. Am J Physiol Heart Circ Physiol. 2005;288:H371–81. doi:10.1152/ajpheart.01030.2003.

    Article  PubMed  CAS  Google Scholar 

  111. Joussen AM, Poulaki V, Le ML, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18:1450–2.

    PubMed  CAS  Google Scholar 

  112. Kowluru RA, Odenbach S. Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants. Invest Ophthalmol Vis Sci. 2004;45:4161–6. doi:10.1167/iovs.04-0633.

    Article  PubMed  Google Scholar 

  113. Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res. 2007;2007:95103.

    PubMed  Google Scholar 

  114. Adamis AP, Berman AJ. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol. 2008;30:65–84. doi:10.1007/s00281-008-0111-x.

    Article  PubMed  CAS  Google Scholar 

  115. Sirover MA. New nuclear functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells. J Cell Biochem. 2005;95:45–52. doi:10.1002/jcb.20399.

    Article  PubMed  CAS  Google Scholar 

  116. Sirover MA. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta. 1999;1432:159–84.

    PubMed  CAS  Google Scholar 

  117. Sawa A, Khan AA, Hester LD, Snyder SH. Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. Proc Natl Acad Sci U S A. 1997;94:11669–74. doi:10.1073/pnas.94.21.11669.

    Article  PubMed  CAS  Google Scholar 

  118. Hara MR, Cascio MB, Sawa A. GAPDH as a sensor of NO stress. Biochim Biophys Acta. 2006;1762:502–9.

    PubMed  CAS  Google Scholar 

  119. Brown VM, Krynetski EY, Krynetskaia NF, et al. A novel CRM1-mediated nuclear export signal governs nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase following genotoxic stress. J Biol Chem. 2004;279:5984–92. doi:10.1074/jbc.M307071200.

    Article  PubMed  CAS  Google Scholar 

  120. Hara MR, Agrawal N, Kim SF, et al. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol. 2005;7:665–74. doi:10.1038/ncb1268.

    Article  PubMed  CAS  Google Scholar 

  121. Jenkins JL, Tanner JJ. High-resolution structure of human d-glyceraldehyde-3-phosphate dehydrogenase. Acta Crystallogr D Biol Crystallogr. 2006;62:290–301. doi:10.1107/S0907444905042289.

    Article  PubMed  CAS  Google Scholar 

  122. Saunders PA, Chalecka-Franaszek E, Chuang DM. Subcellular distribution of glyceraldehyde-3-phosphate dehydrogenase in cerebellar granule cells undergoing cytosine arabinoside-induced apoptosis. J Neurochem. 1997;69:1820–8.

    Article  PubMed  CAS  Google Scholar 

  123. Lin J, Bierhaus A, Bugert P, et al. Effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy. Diabetologia. 2006;49:1089–96. doi:10.1007/s00125-006-0174-y.

    Article  PubMed  CAS  Google Scholar 

  124. Roberts R, Luan H, Berkowitz BA. Alpha-lipoic acid corrects late-phase supernormal retinal oxygenation response in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci. 2006;47:4077–82.

    Article  PubMed  Google Scholar 

  125. Vincent AM, Russell JW, Low P, Feldman EL. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev. 2004;25:612–28. doi:10.1210/er.2003-0019.

    Article  PubMed  CAS  Google Scholar 

  126. Guerrero-Romero F, Rodríguez-Morán M. Complementary therapies for diabetes: the case for chromium, magnesium, and antioxidants. Arch Med Res. 2005;36:250–7. doi:10.1016/j.arcmed.2005.01.004.

    Article  PubMed  CAS  Google Scholar 

  127. Yülek F, Or M, Ozogul C, et al. Effects of stobadine and vitamin E in diabetes-induced retinal abnormalities: involvement of oxidative stress. Arch Med Res. 2007;38:503–11. doi:10.1016/j.arcmed.2007.02.006.

    Article  PubMed  CAS  Google Scholar 

  128. Yatoh S, Mizutani M, Yokoo T, et al. Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy. Diabetes Metab Res Rev. 2006;22:38–45. doi:10.1002/dmrr.562.

    Article  PubMed  CAS  Google Scholar 

  129. Hammes HP, Du X, Edelstein D, et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med. 2003;9:294–9. doi:10.1038/nm834.

    Article  PubMed  CAS  Google Scholar 

  130. SanGiovanni JP, Chew EY, Clemons TE, et al. Age-Related Eye Disease Study Research Group: the relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol. 2007;125:671–9. doi:10.1001/archopht.25.5.671.

    Article  PubMed  CAS  Google Scholar 

  131. Sabu MC, Smitha K, Ramadasan K. Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J Ethnopharmacol. 2002;83:109–16. doi:10.1016/S0378-8741(02)00217-9.

    Article  PubMed  CAS  Google Scholar 

  132. Mustata GT, Rosca M, Biemel KM, et al. Paradoxical effects of green tea (Camellia sinensis) and antioxidant vitamins in diabetic rats: improved retinopathy and renal mitochondrial defects but deterioration of collagen matrix glycoxidation and cross-linking. Diabetes. 2005;54:517–26. doi:10.2337/diabetes.54.2.517.

    Article  PubMed  CAS  Google Scholar 

  133. Stahl W, Sies H. Bioactivity and protective effects of natural carotenoids. Biochim Biophys Acta. 2004;1740:101–7.

    PubMed  Google Scholar 

  134. Kowluru RA, Menon B, Gierhart D. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rat. Invest Ophthalmol Vis Sci. 2008;49:1645–51. doi:10.1167/iovs.07-0764.

    Article  PubMed  Google Scholar 

  135. Kowluru RA, Kanwar M. Effect of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab (Lond). 2007;4:1–8. doi:10.1186/1743-7075-4-8.

    Article  CAS  Google Scholar 

  136. Zheng L, Du Y, Miller C, et al. Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia. 2007;50:1987–96. doi:10.1007/s00125-007-0734-9.

    Article  PubMed  CAS  Google Scholar 

  137. Millen AE, Gruber M, Klein R, Klein BE, Palta M, Mares JA. Relations of serum ascorbic acid and alpha-tocopherol to diabetic retinopathy in the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2003;158:225–33. doi:10.1093/aje/kwg116.

    Article  PubMed  Google Scholar 

  138. Millen AE, Klein R, Folsom AR, Stevens J, Palta M, Mares JA. Relation between intake of vitamins C and E and risk of diabetic retinopathy in the Atherosclerosis Risk in Communities Study. Am J Clin Nutr. 2004;79:865–73.

    PubMed  CAS  Google Scholar 

  139. Dagher Z, Park YS, Asnaghi V, Hoehn T, Gerhardinger C, Lorenzi M. Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy. Diabetes. 2004;53:2404–11. doi:10.2337/diabetes.53.9.2404.

    Article  PubMed  CAS  Google Scholar 

  140. Sun W, Oates PJ, Coutcher JB, Gerhardinger C, Lorenzi MA. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy. Diabetes. 2006;55:2757–62. doi:10.2337/db06-0138.

    Article  PubMed  CAS  Google Scholar 

  141. Kato N, Yashima S, Suzuki T, Nakayama Y, Jomori T. Long-term treatment with fidarestat suppresses the development of diabetic retinopathy in STZ-induced diabetic rats. J Diab Comp. 2003;17:374–9. doi:10.1016/S1056-8727(02)00193-9.

    Article  Google Scholar 

  142. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci U S A. 1991;88:11555–8. doi:10.1073/pnas.88.24.11555.

    Article  PubMed  CAS  Google Scholar 

  143. Kern TS, Engerman RL. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes. 2001;50:1636–42. doi:10.2337/diabetes.50.7.1636.

    Article  PubMed  CAS  Google Scholar 

  144. Bolton WK, Cattran DC, Williams ME, et al. Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. Am J Nephrol. 2004;24:32–40. doi:10.1159/000075627.

    Article  PubMed  CAS  Google Scholar 

  145. Clermont AC, Takagi C, Jirousek MR, Bursell SE, King GLA. PKC beta isoform selective antagonist normalized retinal blood flow in STZ diabetic rats: first report of an oral agent selective for the PKC beta isoenzyme. Invest Ophthalmol Vis Sci. 1995;36:S173.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. K-404, Kresge Eye Institute, Wayne State University, 4717 St. Antoine, Detroit, MI, 48201, USA

    Sally A. Madsen-Bouterse & Renu A. Kowluru

Authors
  1. Sally A. Madsen-Bouterse
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Renu A. Kowluru
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Renu A. Kowluru.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Madsen-Bouterse, S.A., Kowluru, R.A. Oxidative stress and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord 9, 315–327 (2008). https://doi.org/10.1007/s11154-008-9090-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11154-008-9090-4

Keywords

Search

Navigation